Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Hepatitis C virus infection among methamphetamine-dependent individuals in outpatient treatment.

Gonzales R, Marinelli-Casey P, Shoptaw S, Ang A, Rawson RA.

J Subst Abuse Treat. 2006 Sep;31(2):195-202. Epub 2006 Jul 18.

PMID:
16919748
2.

Hepatitis C infection among drug users in northern Thailand.

Jittiwutikarn J, Thongsawat S, Suriyanon V, Maneekarn N, Celentano D, Razak MH, Srirak N, Vongchak T, Kawichai S, Thomas D, Sripaipan T, Netski D, Ananthakrishnan A, Nelson KE.

Am J Trop Med Hyg. 2006 Jun;74(6):1111-6.

PMID:
16760529
3.

Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.

Loebstein R, Mahagna R, Maor Y, Kurnik D, Elbaz E, Halkin H, Olchovsky D, Ezra D, Almog S.

Isr Med Assoc J. 2008 Nov;10(11):775-8.

4.

Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.

Liu JY, Lin HH, Liu YC, Lee SS, Chen YL, Hung CC, Ko WC, Huang CK, Lai CH, Chen YS, Shih YL, Chung HC, Liang SH, Lin JN.

Clin Infect Dis. 2008 Jun 1;46(11):1761-8. doi: 10.1086/587992.

PMID:
18433337
5.

HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection.

Hagan H, Des Jarlais DC, Stern R, Lelutiu-Weinberger C, Scheinmann R, Strauss S, Flom PL.

Int J Drug Policy. 2007 Oct;18(5):341-51. Epub 2007 May 2. Review.

PMID:
17854721
6.
7.

Prevalence of human immunodeficiency virus and its association with hepatitis B, C, and D virus infections among incarcerated male substance abusers in Taiwan.

Chu FY, Chiang SC, Su FH, Chang YY, Cheng SH.

J Med Virol. 2009 Jun;81(6):973-8. doi: 10.1002/jmv.21481.

PMID:
19382252
8.

Survey of hepatitis B and C in addiction treatment unit.

Dhopesh VP, Taylor KR, Burke WM.

Am J Drug Alcohol Abuse. 2000 Nov;26(4):703-7.

PMID:
11097200
9.

HIV and HCV infection among drug users in Japan.

Wada K, Greberman SB, Konuma K, Hirai S.

Addiction. 1999 Jul;94(7):1063-9.

PMID:
10707444
10.

Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis.

Xia X, Luo J, Bai J, Yu R.

Public Health. 2008 Oct;122(10):990-1003. doi: 10.1016/j.puhe.2008.01.014. Epub 2008 May 19. Review.

PMID:
18486955
11.

Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.

Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S, Mathur A.

Trop Gastroenterol. 2007 Jan-Mar;28(1):19-23.

PMID:
17896605
12.

Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.

Birkhead GS, Klein SJ, Candelas AR, O'Connell DA, Rothman JR, Feldman IS, Tsui DS, Cotroneo RA, Flanigan CA.

Int J Drug Policy. 2007 Oct;18(5):417-25. Epub 2007 Feb 20. Review.

PMID:
17854731
13.

HIV/hepatitis C virus co-infection in drug users: risk behavior and prevention.

Hagan H, Thiede H, Des Jarlais DC.

AIDS. 2005 Oct;19 Suppl 3:S199-207. Review.

PMID:
16251818
14.

Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.

Vicknasingam B, Narayanan S, Navaratnam V.

Drug Alcohol Rev. 2009 Jul;28(4):447-54. doi: 10.1111/j.1465-3362.2009.00087.x.

PMID:
19594801
15.

Systematic review of HIV and HCV infection among drug users in China.

Bao YP, Liu ZM.

Int J STD AIDS. 2009 Jun;20(6):399-405. doi: 10.1258/ijsa.2008.008362. Review.

PMID:
19451325
16.

Hepatitis C infection among drug users attending general practice.

Cullen W, Bury G, Barry J, O'Kelly FD.

Ir J Med Sci. 2003 Jul-Sep;172(3):123-7.

PMID:
14700114
17.

Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran.

Zamani S, Ichikawa S, Nassirimanesh B, Vazirian M, Ichikawa K, Gouya MM, Afshar P, Ono-Kihara M, Ravari SM, Kihara M.

Int J Drug Policy. 2007 Oct;18(5):359-63. Epub 2007 Apr 30.

PMID:
17854723
18.

Hepatitis C meanings and preventive strategies among street-involved young injection drug users in Montréal.

Roy E, Nonn E, Haley N, Cox J.

Int J Drug Policy. 2007 Oct;18(5):397-405. Epub 2007 Apr 24.

PMID:
17854728
19.

The importance of preventing hepatitis C virus infection among injection drug users in the United States.

Alter MJ, Moyer LA.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S6-10.

PMID:
9663617
20.

Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment.

Backmund M, Reimer J, Meyer K, Gerlach JT, Zachoval R.

Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S330-5. Review.

PMID:
15768343

Supplemental Content

Support Center